Let’s step into our patients’ world and explore what it’s like to live with #Lupus 🚨Among the leading causes of death in young women 😔Substantial burden on quality of life 🔁Disease control that is often incomplete 💊Treatments with limitations Sponsored by BMS #Rheumatology

🆕 Visual Abstract with @HealioRheum 🎨 Deucravacitinib in #PsoriaticArthritis: POETYK PsA-2 🎲 Phase 3 RCT: Deucravacitinib vs PBO 💊 #Deucravacitinib = oral, selective TYK2 inhibitor 🥇 1st FDA-approved TYK2i for PsA Healio 🔗: vist.ly/5hps8 #RheumX #Dermatology

🆕 Gout Part 2: In Collaboration with @RheumNow 🔵 Approach to Treatment of Gout: 💊 Acute Treatment Options 💎 Urate Lowering Therapy 🫘 Renal Dose Adjustment for CKD #Gout #Rheumatology #Rheum #UricAcid

🆕 Visual Abstract with @HealioRheum 🟢 Bone Marrow Edema (BME) in the General Population 💡Key Takeaway: BME is NON-specific, and was seen in up to *30%* of healthy people (N >11,000) 📝 Bressem et al, Lancet Rheum 🔗: tinyurl.com/BMEHealio #Rheumatology #RheumX #Radiology

🆕 Phase 3 RCT of #Brepocitinib (TYK2-JAK1 inhibitor) vs PBO in #Dermatomyositis (The VALOR Trial) 🔥 ⌛ Rapid onset: improvements as early as wk 4 💪 All pts had both active muscle + skin disease 📈 Improvement in myositis activity, GC tapering #Myositis #Rheumatology #DermX

🆕 Visual Abstract with @HealioRheum 🟢 GLP1 Receptor Agonist in #PsoriaticArthritis • Ixekizumab (IXE; Taltz) + Tirzepatide (GLP1) was superior to IXE alone in improving PsA disease activity 📝: by Merola et al (A&R) 🔗: tinyurl.com/glp1psa #GLP1 #Rheumatology #RheumX

🆕 Visual Abstract with @HealioRheum RESET-RA Trial: Vagus Nerve Stimulator (VNS) for #RheumatoidArthritis • adults with moderate-to-severe RA • surgically implanted VNS more likely to achieve ACR20 📝 by Tesser et al 🔗: tinyurl.com/VNSRA #RheumX #RheumTwitter #RA

🆕 AAO 2026 Guidelines for #Hydroxychloroquine Retinopathy Screening OCT + FAF (wide-pattern Fundus Autofluorescence) are the primary screening tests for HCQ Retinopathy Why no longer VF? FAF has better recognition of pericentral retinopathy. #RheumX #RheumTwitter #OphthoX

🆕 Visual Abstract with @HealioRheum 🟢 #Telitacicept in Systemic Lupus Erythematosus • telitacicept: TACI-Fc fusion protein which targets BLyS/APRIL • telitacicept had ⇡ response rate vs PBO 📖: van Vollenhoven et al, NEJM 🔗:  tinyurl.com/telitaciceptheal… #RheumX #Lupus #SLE

🆕 Approach to Rheum Labs! 🧪 With the current #rheumatology workforce shortage, better education is needed to increase yield of new patient referrals from referring clinicians: 1️⃣ Joint Pain: when should one refer to #Rheum? 2️⃣ ANA: when should an #ANA be checked? #MedTwitter

🆕 Visual Abstract with @HealioRheum 🟢 Upadacitinib for Treatment of Giant Cell Arteritis • Upadacitinib (JAKi) 15mg, 7.5mg (vs) PBO • UPA 15mg showed superior efficacy to placebo 📖 by Blockmans et al, NEJM 🔗: tinyurl.com/upaGCA #GiantCellArteritis #GCA #RheumX

🆕 2025 ACR Guideline for Treatment of Systemic #Lupus Erythematosus 🦋 Just Released: Nov 3 #ACR25 🔥 🔸Review organ-specific treatment recommendations 🔸Steroid & HCQ Use Guidance ➠ Read the Full Guideline: acr.tw/47mkegj #RheumX #RheumTwitter #Rheum @RheumNow

🆕 Secrets & Pearls of Rheumatology at #ACR25 | Part 1 by @Janetbirdope 🖐️ Cutaneous Pathology SLE/DM 🧴 Tips for SLE  💪 Cancer Screening in Myositis 🩸 Laboratory Testing 🥶 Raynaud's / Scleroderma 👀 Sjogrens Disease #RheumX  #Lupus #Myositis  #Scleroderma #Sjogrens

🆕 Bench to Bedside: Diagnosis & Treatment of #SLE Nephritis #ACR25 🎤 Talks by Dr. Andrea Fava, Dr. Maria Dall’Ara, & Dr. Anca Askanase 🔹Limitations of Using Proteinuria 🔹Applying 2024 ACR LN Guidelines 🔹How to Treat Refractory Disease #LupusNephritis #Lupus #ACR2025

🆕 ACR 2025 Guidelines for Treatment of Systemic Lupus Erythematosus #ACR25 #Lupus #RheumTwitter

🆕 Collaboration with @RheumNow 🔵 3-Part Series on #InterstitialLungDisease Part 3️⃣: Treatment of #ILD 💊 Medication Options for Rx of ILD 💉 🫁 How to Treat Different ILD Subtypes 🚶🏻‍♀️Holistic Approach to Management ❌🚬 #RheumTwitter #PulmTwitter #IPF #PulmX

🆕 Collaboration with @RheumNow 🔵 3-Part Series on #InterstitialLungDisease Part2️⃣: Diagnosis & Subtypes of #ILD 🫁 👩🏻‍⚕️ What to look for on Physical Exam 🧪 Serologic Testing & Diagnostic Workup 🫁 Differentiating ILD Subtypes on Imaging #RheumX #Pulmonology #MedTwitter #MedX

🆕 Collaboration with @RheumNow 🔵 3-Part Series on #InterstitialLungDisease Part I: Introduction to #ILD 🫁 🔹Learn about different subtypes of ILD 🔹Signs/Symptoms of Initial Presentation 🔹What is the prevalence of ILD in various SARDs? #RheumTwitter #PulmTwitter #RheumX

🆕 Behçet's Disease: Let’s explore this multi-system #vasculitis 💫 👄 Oral/Genital Ulcers 🩸 DVT, Arterial Aneurysm 👁️ Uveitis 🧠 Neurologic Involvement 🖐️ Cutaneous / Pathergy #RheumTwitter #Behcets #RheumX

🆕 2024 ACR Guidelines for Screening, Treatment and Management of #Lupus Nephritis🦋 • Just Released: May 7, 2025 🔥 🔸New Recommendations for Triple Therapy for Class III/IV + V 🔸Reduced ⇣ Dose of PO Steroids after IV Pulse! #LupusNephritis #RheumX #RheumTwitter #SLE